0126Z0.KS Overview

Company Profile

Samsung Epis Holdings Co., Ltd., a biotechnology company, manage the portfolio of biopharmaceutical products. The company was founded in 2025 and is based in Incheon, South Korea.

Related stocks

326030.KS • South Korea

SKBP

72,700 KRW

4.25B USD 1Y -30.4%

196170.KQ • South Korea

Alteogen

241,000 KRW

12.53B USD 1Y -33.6%

214450.KQ • South Korea

PharmaResearch

302,500 KRW

2.35B USD 1Y -45%

BIOCON.NS • India

BIOCON LIMITED.

349.4 INR

5.91B USD 1Y +0.3%

302440.KS • South Korea

SKBS

36,750 KRW

2.15B USD 1Y -22.6%

3759.HK • China

PHARMARON

30.6 HKD

7.16B USD 1Y +9.4%

6821.HK • China

ASYMCHEM

155.1 HKD

7.15B USD 1Y +60.9%

688578.SS • China

SHANGHAI ALLIST PHARMACEUTICALS

82.5 CNY

5.56B USD 1Y -23%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

5 Metrics

Country

Region

Sector

Industry

Website

https://www.samsungepisholdings.com/en/

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

3Y Volatility

Max Drawdown (3Y)

Sharpe Ratio (3Y)

Size Class

Mega Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections